Lisa Emm, MD
Obstetrics & Gynecology · Bloomington, ILNPI 1386665966
Payments from drug & device makers
Across 100 payments — averaging $17.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sumitomo Pharma America, Inc.$575
- AbbVie$213
- Astellas Pharma US Inc$126
- Biogen$109
- Novo Nordisk$89
- Pfizer$88
- plus $580 from 17 others
What the payments were for
- Food & beverage$1,75699%
- Education$241%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sumitomo Pharma America, Inc. | 34 | $575 |
| AbbVie | 10 | $213 |
| Astellas Pharma US Inc | 6 | $126 |
| Biogen | 6 | $109 |
| Novo Nordisk | 5 | $89 |
| Pfizer | 5 | $88 |
| Bayer | 5 | $86 |
| Exeltis, USA Inc. | 4 | $68 |
| Mayne Pharma Commercial LLC | 2 | $46 |
| Organon | 2 | $44 |
| Baxter Healthcare | 2 | $37 |
| Heron Therapeutics, Inc. | 2 | $36 |
| Exact Sciences | 2 | $34 |
| Eisai Inc. | 2 | $33 |
| Minerva Surgical, Inc | 2 | $29 |
| Hologic Sales And Service, LLC | 2 | $29 |
| Radius Health, Inc. | 2 | $27 |
| Lupin Inc. | 2 | $25 |
| AMAG Pharmaceuticals, Inc. | 1 | $24 |
| Evofem Biosciences, Inc. | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Boston Scientific | 1 | $15 |
| Therapeuticsmd, Inc. | 1 | $12 |
How this compares
$1,780 in reported general payments places this provider in the 75th percentile of 1,732 obstetrics & gynecology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OsphenaOspemifene | 13 | $4,116 |
| Estradiol | 56 | $2,095 |
| ValacyclovirValacyclovir Hcl | 14 | $391 |
| Levothyroxine Sodium | 29 | $238 |
| Alendronate Sodium | 23 | $158 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Bloomington
- Phyllis MarxSkokie$2M
- Mary Jenkins VogelEvanston$886K
- Charles MillerNaperville$603K
- Lee ShulmanChicago$577K
- Anne SchaibleOak Lawn$546K
- Christopher OlsonNaperville$530K
- Laura PearlmanSkokie$426K
- Maria TamChicago$378K
- Amy WhitakerChicago$351K
- Gregory UrsinoChicago$242K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.